Halozyme Therapeutics (HALO) Says AbbVie (ABBV) Discontinued Development Using Halozyme ENHANZE
Tweet Send to a Friend
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that AbbVie (NYSE: ABBV) has discontinued a development program using ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
